Výsledky vyhledávání - "Denise Eustace"

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

Autor: Patricia A. MacDonald, William A. Palo, Robert L. Wortmann, Laurent Vernillet, H. Ralph Schumacher, Nancy Joseph-Ridge, Denise Eustace, Michael Becker

Publikováno v: Arthritis & Rheumatism. 52:916-923

Objective Gout affects ∼1–2% of the American population. Current options for treating hyperuricemia in chronic gout are limited. The purpose of this study was to assess the safety and efficacy of febuxostat, a nonpurine selective inhibitor of xan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ac80016e92b4eceff169424c52a67d8
https://doi.org/10.1002/art.20935

Zobrazit plný text záznamu

Akademický článek

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty‐eight–day, multicenter, phase II, randomized, double‐blind, placebo‐controlled, dose‐response clinical trial examining safety and efficacy in patients with gout

Autor: Michael A. Becker, H. Ralph Schumacher, Robert L. Wortmann, Patricia A. MacDonald, William A. Palo, Denise Eustace, Laurent Vernillet, Nancy Joseph‐Ridge

Publikováno v: Arthritis & Rheumatism; Mar2005, Vol. 52 Issue 3, p916-923, 8p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání